BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

865 related articles for article (PubMed ID: 15618239)

  • 1. Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system.
    Lee HS; Lee MS; Lee SM; Lee SY; Lee ES; Lee EY; Park SY; Han JS; Kim S; Lee JS
    Nephrol Dial Transplant; 2005 Feb; 20(2):342-8. PubMed ID: 15618239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors predicting progression of IgA nephropathies.
    Coppo R; D'Amico G
    J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk factors affecting the long-term outcome of IgA nephropathy].
    Yang NS; Wu QQ; Du Y; Zhang R; Li YJ; Ye RG; Yu XQ
    Zhonghua Nei Ke Za Zhi; 2005 Aug; 44(8):597-600. PubMed ID: 16194415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
    Manno C; Strippoli GF; D'Altri C; Torres D; Rossini M; Schena FP
    Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and natural history of IgA nephropathy.
    Rychlik I; Andrassy K; Waldherr R; Zuna I; Tesar V; Jancová E; Stejskalová A; Ritz E
    Ann Med Interne (Paris); 1999 Feb; 150(2):117-26. PubMed ID: 10392260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of focal and segmental hyalinosis and sclerosis (FSHS) and nephrotic range proteinuria in IgA nephropathy.
    Packham DK; Yan HD; Hewitson TD; Nicholls KM; Fairley KF; Kincaid-Smith P; Becker GJ
    Clin Nephrol; 1996 Oct; 46(4):225-9. PubMed ID: 8905206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease, and a review of the literature.
    Ibels LS; Györy AZ
    Medicine (Baltimore); 1994 Mar; 73(2):79-102. PubMed ID: 8152367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presentation, prognosis and outcome of IgA nephropathy in Indian adults.
    Chacko B; John GT; Neelakantan N; Korula A; Balakrishnan N; Kirubakaran MG; Jacob CK
    Nephrology (Carlton); 2005 Oct; 10(5):496-503. PubMed ID: 16221102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgA nephropathy in Korea: a morphological and clinical study.
    Lee HS; Koh HI; Lee HB; Park HC
    Clin Nephrol; 1987 Mar; 27(3):131-40. PubMed ID: 3552343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR.
    Komatsu H; Fujimoto S; Sato Y; Hara S; Yamada K; Morita S; Eto T
    J Nephrol; 2005; 18(6):690-5. PubMed ID: 16358226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The retrospective analysis of 343 Czech patients with IgA nephropathy--one centre experience.
    Maixnerova D; Bauerova L; Skibova J; Rysava R; Reiterova J; Merta M; Honsova E; Tesar V
    Nephrol Dial Transplant; 2012 Apr; 27(4):1492-8. PubMed ID: 21891776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
    Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgA nephropathy: 23 years of follow-up.
    Milovanceva-Popovska M; Grcevska L; Dzikova S; Ristovska V; Nikolov V; Polenakovic M
    Prilozi; 2006 Dec; 27(2):13-27. PubMed ID: 17211288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.
    Le W; Liang S; Hu Y; Deng K; Bao H; Zeng C; Liu Z
    Nephrol Dial Transplant; 2012 Apr; 27(4):1479-85. PubMed ID: 21965586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An important role of glomerular segmental lesions on progression of IgA nephropathy: a multivariate analysis.
    Katafuchi R; Oh Y; Hori K; Komota T; Yanase T; Ikeda K; Omura T; Fujimi S
    Clin Nephrol; 1994 Apr; 41(4):191-8. PubMed ID: 8026110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant hypertension in IgA nephropathy was not associated with background pathological phenotypes of glomerular lesions.
    Jiang L; Zhang JJ; Lv JC; Liu G; Zou WZ; Zhao MH; Zhang H
    Nephrol Dial Transplant; 2008 Dec; 23(12):3921-7. PubMed ID: 18603547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tubular lesions determine prognosis of IgA nephropathy.
    Daniel L; Saingra Y; Giorgi R; Bouvier C; Pellissier JF; Berland Y
    Am J Kidney Dis; 2000 Jan; 35(1):13-20. PubMed ID: 10620538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spectrum of acute renal failure in IgA nephropathy.
    Wen YK; Chen ML
    Ren Fail; 2010 May; 32(4):428-33. PubMed ID: 20446779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of renal clinicopathological changes in IgA nephropathy by urinary podocytes excretion and podocalyxin expression.
    Jiang WL; Peng YM; Liu YH; Liu H; Chen GC; Xu XQ; Zhu XJ; Liu FY
    Ren Fail; 2012; 34(7):821-6. PubMed ID: 22679920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.